marcus evans : Asia Drug Discovery & Development
marcus evans summits  
More Information
Endorser
marcus evans: media partner IDMA
IDMA
Media Partner
marcus evans: media partner Arabmedicare.com
Arabmedicare.com
Media Partner
marcus evans: media partner Asia Monitor
Asia Monitor
Media Partner
marcus evans: media partner Express Pharma
Express Pharma
Media Partner
marcus evans: media partner World Generic Markets
World Generic Markets
Media Partner
marcus evans: media partner Drug Delivery Insight
Drug Delivery Insight
International Media Partner
marcus evans: media partner Biopharmalife
Biopharmalife
Media Partner
marcus evans: media partner Modern Pharmaceuticals
Modern Pharmaceuticals
Media Partner
marcus evans: media partner Drugs
Drugs
Media Partner
marcus evans: media partner Drugs in R & D
Drugs in R & D
Media Partner
marcus evans: media partner Clinical Drug Investigation
Clinical Drug Investigation
Media Partner
marcus evans: media partner International Journal of Pharmaceutical Medicine
International Journal of Pharmaceutical Medicine
Media Partner
marcus evans: media partner Molecular Diagnosis & Therapy
Molecular Diagnosis & Therapy
  Asia Drug Discovery & Development
20-22 March 2006, Hotel Taj Lands End | Mumbai, India
 The Summit


The Event

Pressure to reduce time-to-market and improve overall business performance has forced pharmaceutical companies to analyse existing drug development/production cycle strategies, and explore new market and manufacturing centre options. An area of exciting opportunity is the Asia Pacific region. The pharmaceutical market in Asia Pacific is expanding at a faster rate than in the so-calledestablished markets. The region’s 3.6 billion population (60 percent of the world) and its increasing proportion of middle class are key drivers behind this demand.

Outsourcing in Asia provides a way for US and European medical companies to reduce expenses and increase productivity and efficiency. Currently, about 25% of medical companies outsource to Asia to some extent. Although IP protection issues still linger, some US companies are now outsourcing all phases of product development, including drug discovery, research and development, clinical trials, and manufacturing. US and European companies will continue to outsource to Asia as these medical communities develop and cost reductions become more evident.

The Drug Discovery & Devlopment Asia Summit is an exclusive gathering that will bring together senior-level pharmaceutical executives with a select and diversified group of leading-edge Solution Providers to converge over these vital industry issues. Within a focused and professional environment, The Drug Discovery Asia Summit will seamlessly integrate one-on-one meetings and informal networking with leisure activities. Qualified invitation only Delegates will meet with Solution Provider representatives via pre-scheduled and tailored one-on-one meetings.

R.O.I SNAPSHOT - REASONS WHY YOU SHOULD ATTEND

Guaranteed one-on-one business meetings with targeted and highly pre-qualified senior decision makers

• Networking - Focused, undisrupted and extensive networking opportunities with a captive audience of senior decision makers

• Visibility - Through our website, delegates will receive direct exposure to your products and services prior to the Summit

• Prepared - Advanced notification of delegates attending via access to a secured event website prior to your meetings, so you can customise a presentation based on the selected company's individual requirements

• Exclusive - Strict limitation of solution providers in individual categories

• Relationship building - Seating at meals with preferred delegates for personal networking

• Branding - Your Company logo and description on event signage at the Summit

• Information - Understand the issues facing your clients by attending Keynote presentations

marcus evans summits